Anil Karihaloo

Company: Novo Nordisk

Job title: Sr Principal Res Scientist

Seminars:

Panel & Audience Discussion: Collaborative Strategies for Advancing Antifibrotic Drug Development Across Diverse Disease Indications 4:00 pm

This panel discussion gathers experts from across the various disease indications to discuss what is needed to collectively advance antifibrotic drug development across the broad spectrum of diseases. Expect coverage of: With an increase recognition of the complexity and heterogeneity of fibrotic diseases, will combination therapies be necessary to secure clinical efficacy above the current…Read more

day: Day One